Literature DB >> 29140571

Is overactive bladder microvasculature disease a component of systemic atheroscleorosis?

Ahmet Ozgur Yeniel1, Ahmet Mete Ergenoglu1, Reci Meseri2, Erkan Kismali3, Anıl Ari1, Gulgun Kavukcu3, Hikmet H Aydin4, Handan Ak4, Sevcan Atay4, Ismail Mete Itil1.   

Abstract

AIMS: To evaluate the relationship between overactive bladder (OAB) and systemic atherosclerosis in a cohort of women.
METHODS: In this case-control study, we assessed atherosclerosis indicators, such as Framingham risk scores and carotid and femoral artery intima-media thickness, and evaluated possible bladder wall responses to atherosclerosis using endovaginal color Doppler ultrasound and the detection of urinary cytokines in women with OAB and in controls. Quantitative assessment of blood perfusion at the bladder neck was performed using a method that allows for the dynamic monitoring of flow in a predefined region of interest at every point of the cardiac cycle. The independent samples t-test was used to evaluate the relationship between OAB and the atherosclerotic findings when parametric conditions were met, and the Mann-Whitney U test was used when parametric conditions were not met. Kendall's Tau was used to assess the correlation between OAB severity and the atherosclerotic variables. P < 0.05 was considered statistically significant.
RESULTS: There were 74 OAB patients and 73 controls; in total, 147 women were evaluated. We found that all atherosclerosis indicators were significantly associated with OAB and that there was a significant relationship between OAB and decreased bladder neck perfusion. Additionally, there were correlations of OAB severity with systemic atherosclerosis and impaired vascular perfusion of the bladder.
CONCLUSIONS: Decreased perfusion at the bladder neck, the Framingham scores in severe OAB, and the correlation between them suggest that OAB microvascular disease may be a component of systemic atherosclerosis rather than a separate process.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  atherosclerosis; color doppler ultrasound; framingham scores; overactive bladder

Mesh:

Year:  2017        PMID: 29140571     DOI: 10.1002/nau.23452

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  6 in total

1.  Cerebral White Matter Disease and Response to Anti-Cholinergic Medication for Overactive Bladder in an Age-Matched Cohort.

Authors:  David Sheyn; Sangeeta T Mahajan; Adonis Hijaz; Emily Slopnick; Graham Chapman; Sherif El-Nashar; Jeffrey M Mangel
Journal:  Int Urogynecol J       Date:  2019-05-31       Impact factor: 2.894

2.  Relationship between the Severity of Coronary Artery Disease and Overactive Bladder.

Authors:  Gökhan Ceyhun; Güven Erbay
Journal:  Acta Cardiol Sin       Date:  2021-05       Impact factor: 2.672

3.  Urgency urinary incontinence, loss of independence, and increased mortality in older adults: A cohort study.

Authors:  Takashi Yoshioka; Tsukasa Kamitani; Kenji Omae; Sayaka Shimizu; Shunichi Fukuhara; Yosuke Yamamoto
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240

4.  Clinical Relevance of Urine Flow Rate and Exposure to Polycyclic Aromatic Hydrocarbons.

Authors:  Po-Hsuan Jeng; Tien-Ru Huang; Chung-Ching Wang; Wei-Liang Chen
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

5.  Is There a Link Between Carotid Atherosclerosis and Idiopathic Overactive Bladder Among Women with Metabolic Syndrome?

Authors:  Gustavo Teixeira Fulton Schimit; Emerson Pereira Gregorio; Marcio Augusto Averbeck; Matheus Junges de Souza; Acsa Caroline Mesquita da Silva; Danielle Romano Tavares; Silvio Henrique Maia de Almeida
Journal:  Res Rep Urol       Date:  2020-02-19

Review 6.  The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A.

Authors:  Chung-Cheng Wang; Yung-Hong Jiang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2020-03-16       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.